Cargando…

Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients

AIM: We aimed to identify the ability of serum bile acids (BAs) and unsaturated fatty acids (UFAs) profiles to predict the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) patients. METHODS: We first used univariate and multivariate analysis to compare 15 serum BA and 11 U...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Susu, Guo, Lin, Wang, Sijing, Chen, Lijuan, Chang, Hang, Hang, Bo, Mao, Jianhua, Snijders, Antoine M, Lu, Yibing, Ding, Dafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351529/
https://www.ncbi.nlm.nih.gov/pubmed/37465650
http://dx.doi.org/10.2147/DMSO.S411522
_version_ 1785074350945206272
author Feng, Susu
Guo, Lin
Wang, Sijing
Chen, Lijuan
Chang, Hang
Hang, Bo
Mao, Jianhua
Snijders, Antoine M
Lu, Yibing
Ding, Dafa
author_facet Feng, Susu
Guo, Lin
Wang, Sijing
Chen, Lijuan
Chang, Hang
Hang, Bo
Mao, Jianhua
Snijders, Antoine M
Lu, Yibing
Ding, Dafa
author_sort Feng, Susu
collection PubMed
description AIM: We aimed to identify the ability of serum bile acids (BAs) and unsaturated fatty acids (UFAs) profiles to predict the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) patients. METHODS: We first used univariate and multivariate analysis to compare 15 serum BA and 11 UFA levels in healthy control (HC) group (n = 82), T2DM patients with DR (n = 58) and T2DM patients without DR (n = 60). Forty T2DM patients were considered for validation. Then, the receiver operating characteristic curve (ROC) and decision curve analysis were used to assess the diagnostic value and clinical benefit of serum biomarkers alone, clinical variables alone or in combination, and the area under the curve (AUC), integrated discrimination improvement (IDI), and net reclassification improvement (NRI) were used to further assess whether the addition of biomarkers significantly improved the predictive ability of the model. RESULTS: Orthogonal partial least squares-discriminant analysis (OPLS-DA) of serum BAs and UFAs separated the three cohorts including HC, T2DM patients with or without DR. The difference in serum BA and UFA profiles of T2DM patients with or without DR was mainly manifested in the three metabolites of taurolithocholic acid (TLCA), tauroursodeoxycholic acid (TUDCA) and arachidonic acid (AA). Together, they had an AUC of 0.785 (0.918 for validation cohort) for predicting DR in T2DM patients. After adjusting for numerous confounding factors, TLCA, TUDCA, and AA were independent predictors that differentiated T2DM with or without DR. The results of AUC, IDI, and NRI demonstrated that adding these three biomarkers to a model with clinical variables statistically increased their predictive value and were replicated in our independent validation cohort. CONCLUSION: These findings highlight the association of three metabolites, TLCA, TUDCA and AA, with DR and may indicate their potential value in the pathogenesis of DR.
format Online
Article
Text
id pubmed-10351529
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103515292023-07-18 Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients Feng, Susu Guo, Lin Wang, Sijing Chen, Lijuan Chang, Hang Hang, Bo Mao, Jianhua Snijders, Antoine M Lu, Yibing Ding, Dafa Diabetes Metab Syndr Obes Original Research AIM: We aimed to identify the ability of serum bile acids (BAs) and unsaturated fatty acids (UFAs) profiles to predict the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) patients. METHODS: We first used univariate and multivariate analysis to compare 15 serum BA and 11 UFA levels in healthy control (HC) group (n = 82), T2DM patients with DR (n = 58) and T2DM patients without DR (n = 60). Forty T2DM patients were considered for validation. Then, the receiver operating characteristic curve (ROC) and decision curve analysis were used to assess the diagnostic value and clinical benefit of serum biomarkers alone, clinical variables alone or in combination, and the area under the curve (AUC), integrated discrimination improvement (IDI), and net reclassification improvement (NRI) were used to further assess whether the addition of biomarkers significantly improved the predictive ability of the model. RESULTS: Orthogonal partial least squares-discriminant analysis (OPLS-DA) of serum BAs and UFAs separated the three cohorts including HC, T2DM patients with or without DR. The difference in serum BA and UFA profiles of T2DM patients with or without DR was mainly manifested in the three metabolites of taurolithocholic acid (TLCA), tauroursodeoxycholic acid (TUDCA) and arachidonic acid (AA). Together, they had an AUC of 0.785 (0.918 for validation cohort) for predicting DR in T2DM patients. After adjusting for numerous confounding factors, TLCA, TUDCA, and AA were independent predictors that differentiated T2DM with or without DR. The results of AUC, IDI, and NRI demonstrated that adding these three biomarkers to a model with clinical variables statistically increased their predictive value and were replicated in our independent validation cohort. CONCLUSION: These findings highlight the association of three metabolites, TLCA, TUDCA and AA, with DR and may indicate their potential value in the pathogenesis of DR. Dove 2023-07-13 /pmc/articles/PMC10351529/ /pubmed/37465650 http://dx.doi.org/10.2147/DMSO.S411522 Text en © 2023 Feng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Feng, Susu
Guo, Lin
Wang, Sijing
Chen, Lijuan
Chang, Hang
Hang, Bo
Mao, Jianhua
Snijders, Antoine M
Lu, Yibing
Ding, Dafa
Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients
title Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients
title_full Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients
title_fullStr Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients
title_full_unstemmed Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients
title_short Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients
title_sort association of serum bile acid and unsaturated fatty acid profiles with the risk of diabetic retinopathy in type 2 diabetic patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351529/
https://www.ncbi.nlm.nih.gov/pubmed/37465650
http://dx.doi.org/10.2147/DMSO.S411522
work_keys_str_mv AT fengsusu associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT guolin associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT wangsijing associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT chenlijuan associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT changhang associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT hangbo associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT maojianhua associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT snijdersantoinem associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT luyibing associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients
AT dingdafa associationofserumbileacidandunsaturatedfattyacidprofileswiththeriskofdiabeticretinopathyintype2diabeticpatients